Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2016-05-18
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Cycling on Executive Control
NCT03499977
The Effects of Exercise on Executive Functions
NCT03852368
Training Executive Functions to Facilitate Recovery Following Traumatic Brain Injury
NCT01993407
Computerized Cognitive Training for MCI
NCT03232047
Cognitive Training for Attention Deficit Hyperactivity Disorder and Developmental Delays
NCT06277440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active control
Training
25 training sessions of 15 minutes per day, 5 days a week for a month of crystallised intelligence
Inhibitor control
Training
25 training sessions of 15 minutes per day, 5 days a week for a month of inhibitory control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training
25 training sessions of 15 minutes per day, 5 days a week for a month of crystallised intelligence
Training
25 training sessions of 15 minutes per day, 5 days a week for a month of inhibitory control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* girl or boy ;
* French mother tongue;
* Handedness: Right;
* Schooled in a level corresponding to its age (2nd or 1st)
* Informed consent signed by the (s) holder (s) of parental authority, in agreement with the teenager
* Normal medical, neurological, neuroradiological examinations.
* Health insurance
Exclusion Criteria
* Abuse or substance dependence (excluding nicotine) or a toxic over 5 years or has led to comas (overdoses)
* Cognitive disorders of sudden onset that may reflect a stroke; history of head trauma with loss of consciousness for more than 1 hour, or encephalitis;
* A chronic neurological disorder, psychiatric, endocrine, hepatic and infectious disorder;
* Major disease history (diabetes, chronic lung disease, heart disorder, metabolic, hematologic, endocrine or immunological severe cancer);
* A medication that may interfere with brain imaging measures (psychotropic drugs, hypnotics, anxiolytics, antipsychotics, anti-Parkinson, benzodiazepines, anti-inflammatory drugs, antiepileptics, antihistamines, analgesics and muscle relaxants central);
* dyschromatopsia
* Impossibility to submit itself to the study for geographical or psychiatric reasons;
* Pregnant and lactating women;
* Has pervasive developmental disorders and / or acquisitions identified by parents or legal guardian and (or) the teachers;
* Cerebral palsy;
* Fine motor disorder
* Unaccompanied by parent (s) (s) or at least a person with parental authority during the visit to the research platform;
* Tattoo on the head, neck or shoulders
16 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre National de la Recherche Scientifique, France
OTHER
Centre Hospitalier St Anne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine OPPENHEIM
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Sainte-Anne
Arnaud Cachia, PhD, Pr
Role: STUDY_DIRECTOR
University Paris Descartes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Recherche Clinique (CRC) - CHSA
Paris, , France
Centre Hospitalier Sainte-Anne
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ahr E, Houde O, Borst G. Inhibition of the mirror generalization process in reading in school-aged children. J Exp Child Psychol. 2016 May;145:157-65. doi: 10.1016/j.jecp.2015.12.009. Epub 2016 Jan 27.
Cachia A, Borst G, Vidal J, Fischer C, Pineau A, Mangin JF, Houde O. The shape of the ACC contributes to cognitive control efficiency in preschoolers. J Cogn Neurosci. 2014 Jan;26(1):96-106. doi: 10.1162/jocn_a_00459. Epub 2013 Aug 5.
Borst G, Cachia A, Vidal J, Simon G, Fischer C, Pineau A, Poirel N, Mangin JF, Houde O. Folding of the anterior cingulate cortex partially explains inhibitory control during childhood: a longitudinal study. Dev Cogn Neurosci. 2014 Jul;9:126-35. doi: 10.1016/j.dcn.2014.02.006. Epub 2014 Feb 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A00811-48
Identifier Type: OTHER
Identifier Source: secondary_id
D15-P017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.